Saroja Pharma Industries India Limited (NSE:SAROJA)
India flag India · Delayed Price · Currency is INR
43.70
-2.30 (-5.00%)
At close: Sep 26, 2025

NSE:SAROJA Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
176152141---
Upgrade
Market Cap Growth
-17.08%7.55%----
Upgrade
Enterprise Value
267226188---
Upgrade
Last Close Price
43.7037.7535.10---
Upgrade
PE Ratio
17.0014.6816.07---
Upgrade
PS Ratio
0.330.280.35---
Upgrade
PB Ratio
1.120.970.96---
Upgrade
P/TBV Ratio
1.120.970.96---
Upgrade
P/OCF Ratio
15.3013.2213.77---
Upgrade
EV/Sales Ratio
0.500.420.46---
Upgrade
EV/EBITDA Ratio
9.327.896.96---
Upgrade
EV/EBIT Ratio
9.718.217.21---
Upgrade
Debt / Equity Ratio
0.600.600.392.001.533.22
Upgrade
Debt / EBITDA Ratio
3.303.302.133.672.722.20
Upgrade
Asset Turnover
1.631.631.702.724.695.62
Upgrade
Inventory Turnover
195.81195.8116.7220.9189.7172.25
Upgrade
Quick Ratio
1.201.201.840.901.461.26
Upgrade
Current Ratio
1.211.211.891.201.541.38
Upgrade
Return on Equity (ROE)
6.82%6.82%8.90%23.28%45.95%128.24%
Upgrade
Return on Assets (ROA)
5.20%5.20%6.80%9.21%11.66%12.96%
Upgrade
Return on Capital (ROIC)
7.55%7.55%9.13%13.34%19.60%28.76%
Upgrade
Return on Capital Employed (ROCE)
16.10%16.10%15.10%34.30%38.70%57.40%
Upgrade
Earnings Yield
5.89%6.81%6.22%---
Upgrade
FCF Yield
-8.23%-9.53%-26.25%---
Upgrade
Buyback Yield / Dilution
-13.89%-13.89%-20.16%-2.16%-5.73%-1992.20%
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.